Skip to content

Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers

ESWT Treatment of Diabetic Foot VS. Standard Care Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01499472
Enrollment
300
Registered
2011-12-26
Start date
2012-01-31
Completion date
2015-01-31
Last updated
2011-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot

Brief summary

The purpose of this study is to determine if Extra-corporeal-shockwave Therapy (ESWT) added to standard of care wound therapy significantly improves time to complete wound healing in diabetic foot wounds.

Interventions

DEVICEshock wave therapy

shock wave therapy given in accordance to wound assessment every 2 weeks for 4 treatments.

DEVICEdermagold shockwave

shock wave therapy given in accordance to wound assessment every 2 weeks for 4 treatments.

PROCEDUREstandard of care

regular care including debridement and bandaging.

Sponsors

Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Signed Informed Consent. 2. Diagnosed with Diabetes. 3. An Active Diabetic Ulcer larger than 5 cm2 4. Sufficient limb perfusion.(e.g no compartment syndrome ankle Brachial Index (ABI)\>=0.5

Exclusion criteria

1. Pregnancy. 2. The patient is under another research protocol. 3. One of the following: A. ABI\<0.5 C.Significant Arterial-Venous injury. D. Lymphedema. 4. The patient underwent Chemotherapy or Radiotherapy 60 days or less prior to recruitment date. 5. Sufficient Noncompliant. 6. Sickle Cell Anemia, HIV, Immunodeficiency, HgB Anemia, DVT, Chronic Renal Failure, Systemic use of Steroids

Design outcomes

Primary

MeasureTime frame
healed ulcer6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026